Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
We explain Who Assigns Index Constituents, detailing the entities involved and the criteria used to determine index composition.
4,671 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Axsome's 2025 earnings season is shaping up as a pivotal moment for investors. This article breaks down what to expec...
As investors prepare for Personalis (PSNL) 2025 earnings, this guide breaks down what to watch, how to interpret the ...
Claude AI projects a multi-year rally for XRP, SOL, and ADA, with end-2026 targets that would mark fresh highs amid i...
As AI data centers surge, Micron stands at a crossroads. This guide dives into where will Micron stock be by 2030, th...
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
A bold plan unfolds as a European crypto treasury targets triple BTC holdings by buying two specialist firms. The mov...
Broadcom stands at a pivotal crossroads as AI spending shifts from pilots to production. This article lays out the ke...
Constellation Energy has moved from a traditional utility to a player tied to data-center power and AI demand. This a...
Space excitement can push stocks higher fast, but gains often fade without lasting fundamentals. Here’s a practical g...
D-Wave Quantum’s stock sprinted higher this week, but a quick rally doesn’t equal a clear buy. This guide breaks down...
Discover FitLife's 2025 earnings story, from revenue drivers to margins and cash flow. This guide breaks down what th...